Restart of the Johnson & Johnson COVID-19 vaccine: A doctor explains why benefits far outweigh risks
The FDA and CDC paused the use of the J&J vaccine on April 13, 2021 because of six initial cases of a rare and dangerous blood clot involving the cerebral venous sinuses.